Concepedia
Statistics
Publications
1
Citations
21
H-Index
Active since
2022
SAMUEL KLEIN is an author specializing in endocrine pharmacotherapy, glucagon receptor agonism, and cardiometabolic risk reduction.
Publications per year
2022–2022
334-OR: Pemvidutide (ALT-801) , a Balanced (1:1) GLP-1/Glucagon Dual Receptor Agonist, Induces Rapid and Marked Weight Loss without the Need for Dose Titration in People with Overweight/Obesity
SAMUEL KLEIN, JOHN J. NESTOR, M. SCOTT HARRIS et al. · Diabetes · 2022 · 21 citations
Medicine, Pharmacology, Pharmacotherapy +17
1–1 of 1